Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Relapsed Refractory Multiple Myeloma 5
Research on two creams (Monobenzon / Imiquimod) together with the standard treatment for advanced or metastatic melanoma (ImMI). Pending

2024-520052-19-04 Malignant Melanoma 9
The Expression of Fibroblast Activation Protein in Patients with Non-Small Cell Lung Cancer Patients Pending

2025-523965-97-00 Non small cell lung cancer 4
A study to test the safety and effects of IOMX-0675, an antibody treatment, alone or with pembrolizumab, in patients with advanced or spread… Pending

2024-517449-14-00 Advanced/metastatic solid tumors 1
PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer Pending

2025-523134-28-00 ABC borderline resectable pancreatic cancer 10
Optimizing Lymph Node Staging in Esophageal Cancer with USPIO-enhanced MRI Pending

2023-506952-26-01 Esophageal cancer 4
A phase 2 trial of capecitabine for recurrent and/or metastatic salivary duct carcinoma – CAESAR trial Pending

2024-516956-16-01 Salivary Duct Carcinoma 10
Study of IBI3009 alone or in combination with other therapies for extensive-stage small cell lung cancer Pending

2025-523972-21-00 Extensive-Stage Small Cell Lung Cancer 7
RESET C2 Pending

2026-525214-62-00 Localised dMMR Colon Cancer 4
Clinical trial (study) comparing the efficacy and safety of mifamurtide versus standard treatment containing sorafenib in pediatric and youn… Pending

2026-525223-24-00 Relapsed/refractory osteosarcoma, High-grade osteosarco 4
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab… Pending

2026-525248-13-00 Advanced Solid Tumors 9
Toripalimab plus chemotherapy as first-line treatment for recurrent and/or metastatic nasopharyngeal cancer: safety and activity in non-ende… Pending

2025-522472-85-00 Recurrent Metastatic Nasopharingeal Carcinoma 5
A Phase II, Randomized, Trial of Niraparib Versus Best Supportive Careas Maintenance Treatment In Patients With Locally Advanced Or Metastat… Pending

2024-519519-32-00 urothelial cancer 4
Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE) Pending

2026-525263-41-00 Hodgkin lymphoma 5
Activity of Pembrolizumab plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (REPRINT trial) Pending

2024-511587-93-00 Medullary Renal cell Carcinoma 4
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) Pending

2025-523997-18-00 Sarcoma 9
Intensified Monitoring of PhArmacology of Cabozantinib as a tool for Toxicity management in patients with renal cell carcinoma Pending

2026-525267-40-00 Renal cell carcinoma 6
A randomized, double-blinded, placebo-controlled, multicenter, phase II/III efficacy and safety study of oral TherO2-01S22 as add-on therapy… Pending

2024-516576-15-00 metastatic breast cancer 10
Phase II, clinical trial, to evaluate OS in two cohorts in relapsed stage III non-small-cell lung cancer (NSCLC) pretreated with chemoradiot… Pending

2024-520081-65-00 NSCLC non-small cell lung cancer 4
Pralsetinib (Gavreto) drug drug interaction study in patients with RET+ advanced or metastatic solid tumors. Pending

2025-523158-15-00 Patients with advanced or metastatic solid tumors 11
A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE… Pending

2023-506982-73-00 high risk or poor response after chemoradiation and bra 4
Phase II trial of amivantamab plus monochemotherapy in platinum unfit NSCLC patients with EGFR exon20 insertion mutations Pending

2025-520676-26-00 Non-small cell lung cancer (NSCLC) 4
Study on the effect of 6qc-ICG on the skin of healthy volunteers and in patients with breast cancer during surgeries. Pending

2025-523166-24-00 Breast cancer 7
Phase I study of CDK8 inhibitor RVU120 in combination with everolimus in children with recurrent or progressive Group 3 or 4 medulloblastoma… Pending

2025-524031-39-00 Medulloblastoma (recurrent or progressive) 3